key: cord-0843793-wkqrgjuc
authors: Rashedi, Sina; Mardani, Mahta; Fooladgar, Milad; Aliannejad, Rasoul
title: Spontaneous pneumomediastinum, pneumopericardium, pneumothorax, and subcutaneous emphysema in a patient with COVID-19
date: 2021-03-03
journal: Radiol Case Rep
DOI: 10.1016/j.radcr.2021.02.069
sha: 45bb434a85414072379446879c4cd174f553ffb1
doc_id: 843793
cord_uid: wkqrgjuc

In this paper, we describe a case of COVID-19 pneumonia complicated by alveolar air leakage syndrome without prior positive pressure ventilation. Our patient was a 55-year-old non-smoker male with a previous history of marginal B-cell lymphoma diagnosed ten years ago who presented to the emergency department with cough, dyspnea, and respiratory distress. The COVID-19 diagnosis was confirmed based on a polymerase chain reaction (PCR) test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The unenhanced chest computed tomography (CT) obtained on the first day of admission demonstrated bilateral multifocal ground-glass opacities and consolidation, extensive pneumomediastinum, bilateral pneumothorax, a rim of pneumopericardium, and right-sided subcutaneous emphysema. Despite the initiation of supportive care, antiviral and antibiotic therapy, he passed away due to septic shock. In conclusion, spontaneous alveolar air leakage, characterized by spontaneous pneumomediastinum, pneumopericardium, pneumothorax, and subcutaneous emphysema, is a rare complication of COVID-19, which may be linked with a severe course of the disease.

In this paper, we describe a case of COVID-19 pneumonia complicated by alveolar air leakage syndrome without prior positive pressure ventilation. Our patient was a 55-year-old non-smoker male with a previous history of marginal B-cell lymphoma diagnosed ten years ago who presented to the emergency department with cough, dyspnea, and respiratory distress. The COVID-19 diagnosis was confirmed based on a polymerase chain reaction (PCR) test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 immunocompromised patients [4, 5] .

Since pneumonia is the most common manifestation of COVID-19, chest computed tomography (CT) has been widely utilized for diagnosis, severity assessment, and monitoring the disease progression [6] . The most common chest CT features of COVID-19 include peripheral ground-glass opacities with or without reticular opacities and consolidations [7] . On the other hand, as the COVID-19 outspread globally, numerous unusual complications in infected patients have been reported [8, 9] . Regarding this, alveolar air leak, characterized by the travel of air into the mediastinum or pleural space via bronchovascular sheaths following ruptured alveoli, has been described in hospitalized COVID-19 patients mostly after invasive ventilation [10].

Herein, we present a case of COVID-19 pneumonia, with a past medical history of lymphoma, complicated by spontaneous pneumomediastinum, pneumopericardium, pneumothorax, and subcutaneous chest wall emphysema without prior positive pressure ventilation.

A 55-year-old non-smoker mildly overweight (body mass index (BMI) of 26.54 kg/m 2 ) male with a previous history of marginal B-cell lymphoma diagnosed ten years ago presented to the emergency department with 15 days of severe dry cough, myalgia, and progressive non-exertional shortness of breath. At presentation, he was ill-appearing and suffering from respiratory distress with oxygen saturation of 74% in ambient air, which was improved to 88% on a nonbreather mask at 12 L/min. His respiratory rate was 32 breaths/min, pulse rate was 110 beats/min, temperature 38.1°C, and blood pressure 110/80 mmHg. On examination, course bilateral respiratory sounds alongside chest wall crepitation was detected. Initial laboratory tests were remarkable for the following: 

Air leak syndrome, including pneumomediastinum, pneumopericardium, pneumothorax, or subcutaneous emphysema, has considerable prevalence; and is primarily caused by chest trauma, cardiothoracic surgery, esophageal perforation, and mechanical ventilation [11, 12] . However, spontaneous alveolar air leakage is a rare phenomenon especially following viral pneumonia.

Although an incidence of 11.6% previously had been reported concerning the severe acute respiratory syndrome (SARS) outbreak [13] , a much lower incidence (0.72%) has been reported in patients with COVID-19 [9].

This condition is hypothesized to be a result of diffuse alveolar damage with an increased intra-alveolar pressure [13, 14] . This pathophysiological process is It can be expected that these coughing spells exerted significant strain on the already injured alveoli, initiating the air leakage. Moreover, steroids, that are used in the management of ARDS in COVID-19, have been postulated to contribute to weakening the pulmonary interstitial tissue leading to alveolar air 14 | P a g e leakage [12] . However, in our patient, the air leakage was developed before the administration of corticosteroids.

While the alveolar air leak is usually self-limiting in healthy individuals, its appearance in patients with severe acute respiratory syndrome (SARS) infection has been demonstrated as a potential predictor of disease severity, higher rates of intubation, and mortality [13] . It is a matter of concern whether the same 

WHO Director-General's remarks at the media briefing on 2019-nCoV

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease

Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis

Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis

COVID-19): A Perspective from China

Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features. Invest Radiol

Lung cavitation in COVID-19 pneumonia

Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome

Spontaneous pneumomediastinum in a male adult with COVID-19 pneumonia